JPRN-UMIN000031347已完成未知
The effect of Enzalutamide and Radium-233 chloride for castration-resistant prostate cancer patients with bone metastasis - The effect of Enzalutamide and Radium-223 chloride for CRPC patients with bone metastasis
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •The case of Distant metastasis other than bone metastasis or visceral metastasis
研究者
相似试验
Unknown
2 期
The Combination Therapy With Ra-223 and EnzalutamideCastration-resistant Prostate CancerBone MetastasesNCT03305224Taro Iguchi, MD, PHD10
已完成
2 期
Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate CancerProstate CancerNCT02199197University of Utah49
进行中（未招募）
2 期
Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate CancerCastration-Resistant Prostate CarcinomaProstate Carcinoma Metastatic in the BoneStage IV Prostate CancerNCT03344211University of Southern California30
Unknown
2 期
Enzalutamide and External Beam Hypofractionated Radiotherapy For Intermediate Risk Localized Prostate CancerProstate CarcinomaNCT03196388Fundación Canaria de Investigación Sanitaria70
进行中（未招募）
1 期
Enzalutamide and hypofractionated radiation therapy in intermediate-risk localized prostate cancerMedDRA version: 19.1Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2015-004617-25-ESFundación Canaria de Investigación Sanitarias